Search Results

Filter
  • 1-10 of  226 results for ""FLUOROQUINOLONES""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Drug resistance in Mycobacterium tuberculosis: molecular mechanisms challenging fluoroquinolones and pyrazinamide effectiveness.

  • Authors : Miotto P; Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Cirillo DM

Subjects: Drug Resistance, Bacterial/Drug Resistance, Bacterial/Drug Resistance, Bacterial/*physiology ; Fluoroquinolones/Fluoroquinolones/Fluoroquinolones/*pharmacology ; Mycobacterium tuberculosis/Mycobacterium tuberculosis/Mycobacterium tuberculosis/*drug effects

  • Source: Chest [Chest] 2015 Apr; Vol. 147 (4), pp. 1135-1143.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Internet ISSN: 1931-3543

Record details

×
Academic Journal

A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections.

  • Authors : Amsden GW; Clinical Pharmacology Research Center, Bassett Healthcare, Cooperstown, NY 13326, USA. ; Graci DM

Subjects: Fluoroquinolones* ; Levofloxacin*; Anti-Infective Agents/Anti-Infective Agents/Anti-Infective Agents/*pharmacokinetics

  • Source: Chest [Chest] 1999 Jul; Vol. 116 (1), pp. 115-9.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

×
Academic Journal

Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones.

  • Authors : Metersky ML; Division of Pulmonary and Critical Care Medicine, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT 06030-1321, USA. ; Ma A

Subjects: Atypical Bacterial Forms*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Fluoroquinolones/Fluoroquinolones/Fluoroquinolones/*therapeutic use

  • Source: Chest [Chest] 2007 Feb; Vol. 131 (2), pp. 466-73.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

×
Academic Journal

Fluoroquinolones vs macrolides in the treatment of Legionnaires disease.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Fluoroquinolones/Fluoroquinolones/Fluoroquinolones/*therapeutic use ; Legionnaires' Disease/Legionnaires' Disease/Legionnaires' Disease/*drug therapy

  • Source: Chest [Chest] 2005 Sep; Vol. 128 (3), pp. 1401-5.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

×
Academic Journal

The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia.

  • Authors : Lamping DL; Health Services Research Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, UK. ; Schroter S

Subjects: Aza Compounds* ; Fluoroquinolones* ; Outcome Assessment, Health Care*

  • Source: Chest [Chest] 2002 Sep; Vol. 122 (3), pp. 920-9.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

×
Academic Journal

Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia.

  • Authors : Dresser LD; Clinical Pharmacokinetics Laboratory, State University of New York at Buffalo, USA.; Niederman MS

Subjects: Fluoroquinolones*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*economics ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use

  • Source: Chest [Chest] 2001 May; Vol. 119 (5), pp. 1439-48.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

×
Academic Journal

Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults.

Subjects: Aza Compounds* ; Fluoroquinolones* ; Quinolines*

  • Source: Chest [Chest] 2001 Jan; Vol. 119 (1), pp. 185-95.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

×
Academic Journal

A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia.

  • Authors : Moola S; University of Natal Medical School, Durban, South Africa.; Hagberg L

Subjects: Fluoroquinolones*; Anti-Infective Agents/Anti-Infective Agents/Anti-Infective Agents/*therapeutic use ; Clarithromycin/Clarithromycin/Clarithromycin/*therapeutic use

  • Source: Chest [Chest] 1999 Oct; Vol. 116 (4), pp. 974-83.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

×
Academic Journal

Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.

Subjects: Fluoroquinolones*; Anti-Infective Agents/Anti-Infective Agents/Anti-Infective Agents/*therapeutic use ; Bronchitis/Bronchitis/Bronchitis/*microbiology

  • Source: Chest [Chest] 1998 Jul; Vol. 114 (1), pp. 120-30.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print ISSN: 0012-3692 (Print)

Record details

×
  • 1-10 of  226 results for ""FLUOROQUINOLONES""